Dual-targeting nanotheranostics for MRI-guided enhanced chemodynamic therapy of hepatoma <i>via</i> regulating the tumor microenvironment-Reference-Cited by-同舟云学术

Dual-targeting nanotheranostics for MRI-guided enhanced chemodynamic therapy of hepatoma via regulating the tumor microenvironment

Published:2023 Issue:44 Volume:52 Page:16433-16441
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Liu Jinwu¹²,Qu Hong²³,Hang Lifeng²^ORCID,Sun Yiqiang⁴^ORCID,Li Wuming²,Chen Yiyu²,Li Hong³^ORCID,Wen Wei⁵,Feng Yanqiu¹,Jiang Guihua²³^ORCID

Affiliation:

1. School of Biomedical Engineering, Southern Medical University, Guangzhou, 510282, P. R. China

2. The Department of Medical Imaging, Guangzhou Key Laboratory of Molecular Functional Imaging and Artificial Intelligence for Major Brain Diseases, Guangdong Second Provincial General Hospital, Guangzhou 518037, P. R. China

3. School of Medicine, Jinan University, Guangzhou, 510632, P. R. China

4. School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250022, P. R. China

5. College of Mechanical and Electrical Engineering, Hainan University, Haikou 570228, P. R. China

Abstract

The dual-targeting function and dual-modality image-guided regulation of the ROS were successfully integrated into a nanosystem for enhanced CDT.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D3DT02715E

Reference47 articles.

1. A human liver cell atlas reveals heterogeneity and epithelial progenitors

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Hepatocellular carcinoma

4. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

5. Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons